Dose reductions of vincristine in children with medulloblastoma treated in the maintenance arm of the prospective multicenter trial HIT'91. [electronic resource]
Producer: 20100217Description: 396-7 p. digitalISSN:- 1439-3824
- Adolescent
- Age Factors
- Antineoplastic Agents, Phytogenic -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Cerebellar Neoplasms -- drug therapy
- Child
- Child, Preschool
- Cisplatin -- administration & dosage
- Combined Modality Therapy
- Disease-Free Survival
- Dose-Response Relationship, Drug
- Female
- Humans
- Lomustine -- administration & dosage
- Male
- Medulloblastoma -- drug therapy
- Neoadjuvant Therapy
- Nervous System Diseases -- chemically induced
- Prospective Studies
- Radiotherapy, Adjuvant
- Risk Factors
- Vincristine -- administration & dosage
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.